Real problem
Health information has outpaced safe interpretation and useful continuity.
Investor overview · Review draft
The asset is not the base model.
The asset is the governed operating system around it.
REGNR8 is building governed health-intelligence infrastructure for safer interpretation, bounded programme design, accountable coaching support and longitudinal case continuity.
The diagnostic-journey business case
A high-cost healthcare problem. A governed, scalable operating layer.
REGNR8 is not being built as another open-ended health chatbot. The investable asset is the governed operating system around the intelligence: controlled sources, structured reports, permission-based handoffs, role separation, human approval, monitoring, escalation, and auditability.
The first commercial wedge is the health consumer already investing in tests, consultations, coaching, wearables, supplements, and optimisation but still lacking coherent interpretation and continuity.
Consumer proof creates the foundation for institutional distribution and later practitioner embedment.
Investor thesis
REGNR8 is a governed diagnostic-journey and health-navigation infrastructure company — not a wellness content business and not an autonomous diagnostic system.
REGNR8 at a glance
How the translation layer works.
This investor infographic provides a visual orientation to the problem, governed workflow, investment rationale and safe round snapshot.
Safe investment snapshot
A focused proof-conversion round.
Capital is intended to advance productisation, governance formalisation, pricing validation, pilot readiness and next-raise evidence.
RaiseUSD $1.0M
Primary capitalUSD $825K
Founder-support secondaryUSD $175KExcluded from operating runway
Pre-money valuationUSD $24.0MManagement fundraising anchor
Post-money valuationUSD $25.0MDerived figure
Round purpose Productisation, governance formalisation, pricing validation, pilot readiness, and next-raise evidence.
Current investment entity Executive Athlete Lab (Pty) Ltd, subject to definitive legal documentation.
Future structure Possible Delaware parent or reorganisation if commercially required and lawfully implemented.
Valuation boundaryThe $24M pre-money valuation is a management fundraising anchor, not a certified valuation, independent valuation opinion, securities-law conclusion, investment advice, or guarantee of investor return.
Why investors care
A governed moat around health intelligence.
The asset sits around the model: approved source libraries, structured extraction objects, permission layers, safety locks, reports, Program Manifest infrastructure, state-aware coaching, monitoring, QA, audit, case continuity and human-supervised improvement.
Governed moat
Bounded, auditable outputs in a trust-sensitive health context.
Clear wedge
Consumer validation first, institutional pathways second, practitioner enablement third.
Evidence path
Governed library to report to Manifest to monitored execution and case evidence.
Governed resource material
What changes when AI is not allowed to answer alone.
REGNR8 is not designed to rely on a base model generating health answers from a prompt. The platform is designed to work inside a closed, governed environment where approved source material is extracted into structured reasoning objects, permission layers, safety locks, scenario tests, report templates and case records.
The difference is not only safer language. It is different system behaviour.
A generic or lightly governed AI response may still collapse complex information into plausible-sounding conclusions. In the digestive-intelligence evidence pack, a complex GI-MAP case could easily be reduced to “dysbiosis,” “leaky gut,” a supplement protocol, an antimicrobial plan or a restrictive diet. The governed REGNR8 approach instead preserves counter-evidence, marks uncertainty, identifies missing context, blocks patient-executable protocols and prepares better questions for qualified review.
This is the investable architecture: source depth, governance, retrieval, report discipline, case continuity and human review working together.
Ungoverned or generic AI
- Responds fluently from the prompt.
- May overinterpret abnormal markers.
- May ignore normal counter-evidence.
- May produce protocols, supplements or diet rules.
- May turn a hypothesis into a confident story.
- Usually leaves weak auditability.
Governed AI alone
- Can follow high-level safety instructions.
- Can refuse obvious restricted requests.
- Can use disclaimers.
- Can still be vulnerable to vague prompts, missing context, retrieval drift and overgeneralisation.
- May not know which source, object, permission layer or case state should control the answer.
REGNR8 closed governed resource environment
- Uses approved extraction libraries.
- Retrieves through domain tags and source-role controls.
- Separates observed facts, patterns, counter-evidence and missing data.
- Blocks diagnosis, dosing, medication changes, product recommendations, cure claims and patient-executable protocols.
- Produces structured reports and longitudinal case records.
- Creates reusable IP, QA evidence and professional-review pathways.
Supporting thesis
The product is not a larger prompt.
It is a governed knowledge-and-evidence operating system.
The Governed Digestive Intelligence evidence pack shows how one approved extraction library changes retrieval, reasoning, output boundaries, report structure and longitudinal case-record creation. The example is deliberately de-identified and remains an internal business and product-development illustration.Internal evidence-pack metrics
20retrieval tags
90indexed cards
12adversarial scenarios
9listed QA checks
These figures describe the internal Digestive Intelligence evidence pack and should not be presented as clinical-performance metrics, diagnostic accuracy, efficacy evidence or external validation.
Restricted investor evidence
Restricted investor evidence — not public clinical material.
This evidence pack is an internal business and product-development illustration. It is not a medical report for patient use, a treatment recommendation, an efficacy claim, a clinical validation study or a substitute for professional care.
REGNR8 does not
- diagnose disease;
- prescribe or recommend treatment;
- select supplements, products or doses;
- change medication;
- claim to find what clinicians missed;
- prove clinical efficacy;
- guarantee earlier diagnosis, recovery or health outcomes.
Public document index
What approved investors can review.
This public section shows the categories of material available, not the documents themselves. Release remains subject to eligibility, NDA where required and management approval.
Business Plan
Strategy, market and operating model.
Confidential · gatedInvestor Appendix
Round context and supporting review.
Confidential · gatedInvestor Snapshot
Round summary with valuation boundaries.
Full file gatedGoverned Digestive Intelligence Evidence Pack
Source and evidence-governance demonstration.
Confidential · gatedHuman Navigator sample report
De-identified interpretation output.
De-identified · gatedProgram Manifest sample
Approved programme object and boundaries.
Confidential · gatedCoach Agent journey mockup
Monitoring and escalation flow.
Confidential · gatedUse-of-funds schedule
Primary-capital allocation.
Confidential · gatedValuation support summary
Management rationale and boundaries.
Confidential · gatedFounder briefing request
Discuss the operating system, evidence path, risks and round context.
Request a briefing →Restricted diligence
Restricted · approved investor access onlyRisk Register & De-risking Plan
Detailed risks, current posture, mitigation actions and formal review gates are withheld from the public page.
Investor boundary
This page is for general information and confidential investor discussion only. It is not an offer of securities, a solicitation, investment advice or a guarantee of product performance or investor return.
Review status
All investment discussions remain subject to definitive documentation, eligibility checks, legal and securities-law review, valuation review, claims-boundary review and professional advice.